Grand Medical Group

About us

Grand Medical Group AG is a group of pharmaceutical companies specialized in the development, production, registration and introduction into medical practice of modern innovative products based on organic, synthetic and herbal compounds.

read more

10 Kornmarkt Street, CH - 6004 Luzern, Switzerland

info@grandmedicalgroup.ch

+41 415880810

GOLAKSIN

PHARMACOLOGIC PROPERTIES

ATC code: G04 BD04, Other urologicals, including antispasmodics, urinary antispasmodics Oxybutynin has both direct antispasmodic action on the smooth muscle of the bladder detrusor muscle as well as anticholinergic action in blocking the muscarinic e?ects of acetylcholine on smooth muscle. These properties cause relaxation of the detrusor muscle of the bladder in patients with an unstable bladder. Oxybutynin increases bladder capacity and reduces the incidence of spontaneous contractions of the detrusor muscle.

THERAPEUTIC INDICATIONS

Adults
Treatment of frequency, urgency or urge incontinence as may occur in bladder overactivity whether due to neurogenic bladder disorders (detrusor hyperre?exia) or idiopathic detrusor overactivity.

Paediatric population
Oxybutynin hydrochloride is indicated for children over 5 years for:
• Urinary incontinence, urgency and frequency in overactive bladder conditions caused by idiopathic overactive bladder or neurogenic bladder dysfunction (detrusor over activity).
Nocturnal enuresis associated with detrusor over activity, in conjunction with non-drug therapy, when other treatment not been successful.

LEAFLETS